Inhibition of dipeptidyl peptidase-4: The mechanisms of action and clinical use of vildagliptin for the management of type 2 diabetes

Inhibition of dipeptidyl peptidase-4: The mechanisms of action and clinical use of vildagliptin for the management of type 2 diabetes

Galina Smushkin, Adrian VellaDivision of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic College of Medicine, Rochester, MN, USAAbstract: Postprandial hyperglycemia in type 2 diabetes is characterized by impaired insulin secretion and action, decreased glucose effectiveness and defec...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Galina Smushkin, Adrian Vella
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2009
Materias:
Specialties of internal medicine
RC581-951
Acceso en línea:https://doaj.org/article/7e28802b23eb4617abb118b1cd3c1245
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares